#INJ Date: 10.5 Medium- to long-term play
Ticker: INJ
Recommended entry prices: 7.5 (5 tranches), 9.5 (3 tranches), 12 (2 tranches), for an average entry around 9. Target: at least a 2x return.
Rationale: Injective’s CEO expects a U.S. spot INJ ETF to launch before 2027, possibly even sooner. A revised S-1 registration statement is also expected to be filed this September, showing that the application process is making progress.
INJ launched in 2022 and climbed to around 53 at its 2024 peak. After the market went through a bull-to-bear transition, it fell along with the broader market. It started rebounding from a bottom around 2.6 and has now reached 7.5. From the peak to the current price, that’s only about a 7x difference—much better than many other coins.
Now it’s also applying for a spot ETF. If approved, it’ll be like having a big brother backing it. What does the big brother do? Provide support. The price can rally, while the big brother helps hold up the bottom. A solid medium- to long-term pick!
Ticker: INJ
Recommended entry prices: 7.5 (5 tranches), 9.5 (3 tranches), 12 (2 tranches), for an average entry around 9. Target: at least a 2x return.
Rationale: Injective’s CEO expects a U.S. spot INJ ETF to launch before 2027, possibly even sooner. A revised S-1 registration statement is also expected to be filed this September, showing that the application process is making progress.
INJ launched in 2022 and climbed to around 53 at its 2024 peak. After the market went through a bull-to-bear transition, it fell along with the broader market. It started rebounding from a bottom around 2.6 and has now reached 7.5. From the peak to the current price, that’s only about a 7x difference—much better than many other coins.
Now it’s also applying for a spot ETF. If approved, it’ll be like having a big brother backing it. What does the big brother do? Provide support. The price can rally, while the big brother helps hold up the bottom. A solid medium- to long-term pick!
